NSE filing, NSE: LODHA. Summary written from the filing by ALFA Finder's alert engine.
Lodha Developers Ltd: key numbers
- Share price
- ₹1,010.50
- Market cap
- ₹1,00,993 Cr
- Revenue (annual)
- ₹16,676 Cr
- Net profit (annual)
- ₹3,428 Cr
- P/E (TTM)
- 24.5×Sector 33.7×
- Promoter holding
- 70.29%-0.02% QoQ
- FII holding
- 25.33%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lodha Developers Ltd
All →Lodha Developers Board Meeting Date
Lodha Developers has scheduled a board meeting on October 30, 2026, to consider unaudited consolidated and standalone results for the quarter and half year ended September 30, 2026. The meeting is a future intimation, and the agenda is proposed only.
Lodha Developers Employee Stock Options
Lodha Developers allotted 27,094 equity shares under its ESOP Scheme 2021-II on October 22, 2026. Each share carries a face value of ₹10.
Lodha Developers Debt & Borrowing: ₹262 Cr
Lodha Developers Limited completed a premature full redemption of non-convertible debentures. The company paid Rs.261.96 Crore on the due date.
- Value
- ₹262.0 Cr
Lodha Developers Debt & Borrowing: ₹5.77 Cr
Lodha Developers Ltd has successfully fulfilled its interest payment obligations for non-convertible debentures, amounting to ₹5.77 Crore.
- Value
- ₹5.77 Cr
Lodha Developers Debt & Borrowing: ₹267.7 Cr
Lodha Developers Limited has completed the full redemption and interest payment for debentures (ISIN INE670K07307). Total cash outflow for the company is ₹267.73 Crore.
- Value
- ₹267.7 Cr
Lodha Developers Other Announcement
Lodha Developers Ltd filed its quarterly shareholding pattern as per SEBI regulations, detailing promoter and public shareholding for the quarter ending September 30, 2026.
Other acquisition announcements
All →Laurus Labs Acquisition Worth ₹32.5 Cr
Laurus Labs approved acquiring 52% of SI & C Resins for Rs. 32.50 Crore. The acquisition makes SI&C a subsidiary for peptide resin manufacturing.
- Value
- ₹32.50 Cr
Laurus Labs Acquisition Worth ₹35.63 Cr
Laurus Labs approved buying 60% of Canada-based CRO Galenvs Sciences for USD 3.75 million (₹35.63 Cr). The deal adds an oligonucleotide R&D arm and North American presence.
- Value
- ₹35.63 Cr
Raghav Productivity Enhancers Acquisition
RPEL acquires 80% of RPEL TRLK Silicatech Private Limited for a nominal cash subscription. The target manufactures silica ramming mass and other refractories in India.
Container Corporation of India Acquisition Worth ₹485.9 Cr
CONCOR placed an order with Braithwaite & Co for 24 rakes of BLSS wagons. The deal, including GST, values at Rs.485.93 Crores.
- Value
- ₹485.9 Cr
- Execution
- Delivery by 20.06.2028
- BLSS wagons (fleet)
- 24.0 rakes
Embassy Developments Acquisition Worth ₹32.65 Cr
Embassy Developments signed an SPA to acquire 50% of Embassy Columbia Pacific ASL for ₹32.65 Crore. The JV will become wholly owned upon closing by December 2026.
- Value
- ₹32.65 Cr
- Execution
- Within the current quarter ending on December 31, 2026
MosChip Technologies Acquisition Worth ₹266.7 Cr
MosChip will acquire Vayavya Labs for Rs.266.71 Crore in cash and shares. Completion awaits RBI and exchange approvals and shareholder approval of a preferential issue.
- Value
- ₹266.7 Cr
- Execution
- Within 15 days of the later of receipt of all requisite approvals or shareholder approval of the preferential issue to VLPL sellers